TAIWAN · TWSE / TPEx
Anya
奧孟亞 · 7776 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$32.151 month -3.0% · 1 year -36.5%
Directors and supervisors hold18,351,81037.4% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold13,658,02127.8% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 李淑惠 | Chairman | 2,161,040 | 2,161,040 | 4.40% | — | — |
| 史格瑞 | Director · President · Major shareholder (10%+) | 5,479,652 | 5,387,652 | 10.97% | — | 6,564,592 |
| 晟德大藥廠股份有限公司 | Director · Major shareholder (10%+) | 8,276,369 | 8,270,369 | 16.84% | — | — |
| 王素琦 | Director (corporate representative) | — | 0 | — | — | — |
| Bhushan Dhruvkumar Desai | Director · Vice president | 2,532,749 | 2,532,749 | 5.16% | — | — |
| 賴亞德（Ｒｉｙａｄｈ Ｌａｉ） | Independent director | — | 0 | — | — | — |
| 邱靖斐 | Independent director | — | 0 | — | — | — |
| Peter Keil | Independent director | — | 0 | — | — | — |
| 蔡依庭 | Chief financial officer · Chief accountant | — | 309,128 | 0.63% | — | — |